THEME: "Global Frontlines: Advancing the Science of Infectious Disease Control"
 07-08 Jul 2025
							07-08 Jul 2025						 Prague, Czech Republic
							Prague, Czech Republic						Research on COVID-19 medicine and vaccines has advanced at an unprecedented pace. mRNA vaccines, like Pfizer-BioNTech and Moderna, have proven highly effective in preventing severe illness and have been pivotal in controlling the pandemic. Viral vector vaccines such as AstraZeneca and Johnson & Johnson also showed strong efficacy. Additionally, treatments like Remdesivir, monoclonal antibodies, and dexamethasone have been used to manage COVID-19 symptoms, especially in severe cases. Ongoing research focuses on adapting vaccines to emerging variants, understanding long COVID, and exploring additional therapies. Global collaboration and continued innovation remain key to pandemic control and future preparedness.